Targeted drug-delivery Systems in the Treatment of Rheumatoid Arthritis: Recent Advancement and Clinical Status

References

• Guo Q , WangY , XuD , NossentJ , PavlosNJ , XuJ. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res.6(1), 1–14 (2018).
   PubMedGoogle Scholar
• Global RA Network . About Arthritis and RA. https://globalranetwork.org/project/disease-info/
   Google Scholar
• India . Arthritis. www.arthritis-india.com/rheumatoid-arthritis.html
   Google Scholar
• WHO . Chronic rheumatic conditions. www.who.int/chp/topics/rheumatic/en/
   Google Scholar
• McInnes IB , SchettG. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med.365(23), 2205–2219 (2011).
   PubMed Web of Science ®Google Scholar
• Liao KP , AlfredssonL , KarlsonEW. Environmental influences on risk for rheumatoid arthritis. Curr. Opin. Rheumatol.21(3), 279–283 (2009).
   PubMed Web of Science ®Google Scholar
• McInnes IB , SchettG. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet389(10086), 2328–2337 (2017).
   PubMed Web of Science ®Google Scholar
• Alunno A , CarubbiF , GiacomelliR , GerliR. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol.1(1), 1–13 (2017).
   PubMedGoogle Scholar
• Prosperi D , ColomboM , ZanoniI , GranucciF. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. Semin. Immunol.34, 61–67 (2017).
   PubMed Web of Science ®Google Scholar
• Nissen SE , YeomansND , SolomonDHet al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N. Engl. J. Med.375(26), 2519–2529 (2016).
   PubMed Web of Science ®Google Scholar
• Wilsdon TD , HillCL. Managing the drug treatment of rheumatoid arthritis. Aust. Prescr.40(2), 51–58 (2017).
   PubMed Web of Science ®Google Scholar
• Ayhan E , KesmezacarH , AkgunI. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J. Orthop.5(3), 351 (2014).
   PubMedGoogle Scholar
• Fragoulis GE , McinnesIB , SiebertS. JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatol.58, i43–i54 (2019).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov identifier: NCT03437473. https://clinicaltrials.gov/ct2/show/NCT03437473
   Google Scholar
• ClinicalTrials.gov identifier: NCT00126724. https://clinicaltrials.gov/ct2/show/NCT00126724
   Google Scholar
• ClinicalTrials.gov identifier: NCT01881308. https://clinicaltrials.gov/ct2/show/NCT01881308
   Google Scholar
• ClinicalTrials.gov identifier: NCT00908089. https://clinicaltrials.gov/ct2/show/NCT00908089
   Google Scholar
• Singhvi G , HejmadyS , RapalliVK , DubeySK , DubeyS. Nanocarriers for topical delivery in psoriasis. Deliv. Drugs2, 75–96; Elsevier (2020).
   Google Scholar
• Yang M , FengX , DingJ , ChangF , ChenX. Nanotherapeutics relieve rheumatoid arthritis. J. Control. Rel.252, 108–124 (2017).
   PubMed Web of Science ®Google Scholar
• Singhvi G , RapalliVK , KowthavarapuVK , DubeySK. Alginate: drug delivery and application. Alginates Apple Acad. Press646 (2019).
   Google Scholar
• Rapalli VK , SinghviG , DubeySK , GuptaG , ChellappanDK , DuaK. Emerging landscape in psoriasis management: from topical application to targeting biomolecules. Biomed. Pharmacother.106, 707–713 (2018).
   PubMed Web of Science ®Google Scholar
• Girdhar V , PatilS , BanerjeeS , SinghviG. Nanocarriers for drug delivery: mini review. Curr. Nanomed.8(2), 88–99 (2018).
   Google Scholar
• Mostafavi SH . Nano-sized drug delivery. J. Mol. Pharm. Org. Process Res.1(3), 1–2 (2013).
   Google Scholar
• Levick JR . Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum.24(12), 1550–1560 (1981).
   PubMedGoogle Scholar
• Wardwell PR , ForstnerMB , BaderRA. Investigation of the cytokine response to NF-κB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models. Arthritis Res. Ther.17(1), 310 (2015).
   PubMedGoogle Scholar
• Quan L , ZhangY , CrielaardBJet al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano8(1), 458–466 (2014).
   PubMed Web of Science ®Google Scholar
• Naor D , NedvetzkiS. CD44 in rheumatoid arthritis. Arthritis Res. Ther.5(3), 105–115 (2003).
   PubMed Web of Science ®Google Scholar
• Nagayoshi R , NagaiT , MatsushitaKet al. Effectiveness of anti-folate receptor β antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Arthritis Rheum.52(9), 2666–2675 (2005).
   PubMedGoogle Scholar
• Jubeli E , MoineL , Vergnaud-GauduchonJ , BarrattG. E-selectin as a target for drug delivery and molecular imaging. J. Control. Rel.158(2), 194–206 (2012).
   PubMed Web of Science ®Google Scholar
• Delgado M , AbadC , MartinezCet al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med.80(1), 16–24 (2002).
   PubMed Web of Science ®Google Scholar
• Wilder RL . Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann. Rheum. Dis.61(2), 96–99 (2002).
   Google Scholar
• Nogueira E , LagerF , LeRoux Det al. Enhancing methotrexate tolerance with folate tagged liposomes in arthritic mice. J. Biomed. Nanotechnol.11(12), 2243–2252 (2015).
   PubMed Web of Science ®Google Scholar
• Rapalli VK , KhosaA , SinghviG , GirdharV , JainR , DubeySK. Application of QbD principles in nanocarrier-based drug delivery systems. In: Pharmaceutical Quality by Design.BegS, HasnainMDS ( Eds). Academic Press, MA, USA, 255–296 (2019).
   Google Scholar
• Singhvi G , HansN , ShivaN , KumarDubey S. Xanthan gum in drug delivery applications. In: Natural Polysaccharides in Drug Delivery and Biomedical Applications. HasnainMd S, NayakAK ( Eds). Academic Press, MA, USA, 121–144 (2019).
   Google Scholar
• Gorantla S , WaghuleT , RapalliVKet al. Advanced hydrogels based drug delivery systems for ophthalmic delivery. Recent Pat. Drug Deliv. Formul.doi: 10.2174/187221131466620010809485114 (2020).
   Google Scholar
• Jain S , KrishnaCherukupalli S , MahmoodAet al. Emerging nanoparticulate systems: preparation techniques and stimuli responsive release characteristics. J. Appl. Pharm. Sci.9(08), 130–143 (2019).
   Google Scholar
• Rapalli VK , GorantlaS , WaghuleTet al. Nanotherapies for the treatment of age-related macular degeneration (amd) disease: recent advancements and challenges. Recent Pat. Drug Deliv. Formul. doi:10.2174/187221131466620011709591714 (2020).
   Google Scholar
• Sultana F , NeogMK , RasoolMK. Withaferin-A, a steroidal lactone encapsulated mannose decorated liposomes ameliorates rheumatoid arthritis by intriguing the macrophage repolarization in adjuvant-induced arthritic rats. Colloids Surf B.155, 349–365 (2017).
   PubMed Web of Science ®Google Scholar
• Poh S , ChelvamV , KelderhouseLEet al. Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis. Nanomedicine12(20), 2441–2451 (2017).
   PubMed Web of Science ®Google Scholar
• Zeb A , QureshiOS , YuCHet al. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int. J. Pharm.525(1), 92–100 (2017).
   PubMed Web of Science ®Google Scholar
• Neog MK , RasoolM. Targeted delivery of p-coumaric acid encapsulated mannosylated liposomes to the synovial macrophages inhibits osteoclast formation and bone resorption in the rheumatoid arthritis animal model. Eur. J. Pharm. Biopharm.133, 162–175 (2018).
   PubMed Web of Science ®Google Scholar
• Hua S , DiasTH , PepperallD-G , YangY. Topical loperamide-encapsulated liposomal gel increases the severity of inflammation and accelerates disease progression in the adjuvant-induced model of experimental rheumatoid arthritis. Front. Pharmacol.8, 503 (2017).
   PubMed Web of Science ®Google Scholar
• Meka RR , VenkateshaSH , AcharyaB , MoudgilKD. Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy. Nanomedicine14(11), 1455–1469 (2019).
   PubMed Web of Science ®Google Scholar
• Nogueira E , FreitasJ , LoureiroAet al. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. Colloids Surf B.155, 459–465 (2017).
   PubMed Web of Science ®Google Scholar
• Hu L , LuoX , ZhouSet al. Neutrophil-mediated delivery of dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment. Pharm. Res.36(7), 97 (2019).
   PubMed Web of Science ®Google Scholar
• Xu X-L , LiW-S , WangX-Jet al. Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis. Nanoscale10, 2923 (2018).
   PubMed Web of Science ®Google Scholar
• Hao F , LeeRJ , ZhongLet al. Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy. Theranostics9, 18 (2019).
   Web of Science ®Google Scholar
• Wang Q , JiangH , LiYet al. Targeting NF-κB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials122, 10–22 (2017).
   PubMed Web of Science ®Google Scholar
• Wang X , FengY , FuJet al. A lipid micellar system loaded with dexamethasone palmitate alleviates rheumatoid arthritis. AAPS Pharm. Sci. Tech.20(8), 1–10 (2019).
   Web of Science ®Google Scholar
• Zhang N , XuC , LiNet al. Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation. Drug Deliv.25(1), 1182–1191 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Q , LiY , ChenX , JiangH , ZhangZ , SunX. Optimized in vivo performance of acid-liable micelles for the treatment of rheumatoid arthritis by one single injection. Nano Res.12(2), 421–428 (2019).
   Web of Science ®Google Scholar
• Mohammadi-Samani S , ZojajiS , Entezar-AlmahdiE. Piroxicam loaded solid lipid nanoparticles for topical delivery: preparation, characterization and in vitro permeation assessment. J. Drug Deliv. Sci. Technol.47, 427–433 (2018).
   Web of Science ®Google Scholar
• Gu Y , TangX , YangM , YangD , LiuJ. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Int. J. Pharm.554, 235–244 (2019).
   PubMed Web of Science ®Google Scholar
• Janakiraman K , KrishnaswamiV , SethuramanV , RajendranV , KandasamyR. Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis. Appl. Nanosci.9(8), 1781–1796 (2019).
   Web of Science ®Google Scholar
• Sakdiset P , AmnuaikitT , PichayakornW , PinsuwanS. Formulation development of ethosomes containing indomethacin for transdermal delivery. J. Drug Deliv. Sci. Technol.52, 760–768 (2019).
   Web of Science ®Google Scholar
• Song H , WenJ , LiHet al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int. J. Nanomed.14, 3177–3188 (2019).
   PubMed Web of Science ®Google Scholar
• Duncan R . Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer6(9), 688–701 (2006).
   PubMed Web of Science ®Google Scholar
• Wang D , MillerSC , LiuXM , AndersonB , WangXS , GoldringSR. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res. Ther.9(1), R2 (2007).
   PubMed Web of Science ®Google Scholar
• Li C , LiH , WangQet al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J. Control. Rel.246, 133–141 (2017).
   PubMed Web of Science ®Google Scholar
• Seetharaman G , KallarAR , VijayanVM , MuthuJ , SelvamS. Design, preparation and characterization of pH-responsive prodrug micelles with hydrolyzable anhydride linkages for controlled drug delivery. J. Colloid Interface Sci.492, 61–72 (2017).
   PubMed Web of Science ®Google Scholar
• Vasvani S , KulkarniP , RawtaniD. Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int. J. Biol. Macromol.151, 1012–1029 (2019).
   PubMed Web of Science ®Google Scholar
• Oh EJ , ParkK , KimKSet al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J. Control. Rel.141(1), 2–12 (2010).
   PubMed Web of Science ®Google Scholar
• Schluep T , HwangJ , RodgersK , OliverJC. α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy. Int. J. Nanomedicine3(3), 359 (2008).
   PubMed Web of Science ®Google Scholar
• Yang M , DingJ , FengXet al. Scavenger receptor-mediated targeted treatment of collagen-induced arthritis by dextran sulfate-methotrexate prodrug. Theranostics7(1), 97–105 (2017).
   PubMed Web of Science ®Google Scholar
• Goel N , StephensS. Certolizumab pegol. MAbs2(2), 137–147 (2010).
   PubMed Web of Science ®Google Scholar
• Sundy JS , GansonNJ , KellySJet al. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout. Arthritis Rheum.56(3), 1021–1028 (2007).
   PubMed Web of Science ®Google Scholar
• Prasad LK , O'MaryH , CuiZ. Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine10(13), 2063–2074 (2015).
   PubMed Web of Science ®Google Scholar
• Wang Q , JiangJ , ChenW , JiangH , ZhangZ , SunX. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. J. Control. Release230, 64–72 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Y , LiuZ , LiTet al. Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics9, 3 (2019).
   Web of Science ®Google Scholar
• Mohammadi M , LiY , AbebeDGet al. Folate receptor targeted three-layered micelles and hydrogels for gene delivery to activated macrophages. J. Control. Rel.244, 269–279 (2016).
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A , Rezaei-SadabadyR , DavaranSet al. Liposome: classification, preparation, and applications. Nanoscale Res. Lett.8(1), 1–9 (2013).
   PubMedGoogle Scholar
• Garg A , TisdaleAW , HaidariE , KokkoliE. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. Int. J. Pharm.366(1–2), 201–210 (2009).
   PubMedGoogle Scholar
• Jia M , DengC , LuoJet al. A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. Int. J. Pharm.540(1–2), 57–64 (2018).
   PubMed Web of Science ®Google Scholar
• Sharma G , SainiMK , ThakurKet al. Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study. Nanomedicine12(6), 615–638 (2017).
   PubMed Web of Science ®Google Scholar
• Kumar Sarwa K , RudrapalM , MazumderB. Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug Deliv.22(8), 1043–1052 (2015).
   PubMed Web of Science ®Google Scholar
• Sarwa KK , MazumderB , RudrapalM , VermaVK. Potential of capsaicin-loaded transfersomes in arthritic rats. Drug Deliv.22(5), 638–646 (2015).
   PubMed Web of Science ®Google Scholar
• Abd El-Alim SH , KassemAA , BashaM , SalamaA. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int. J. Pharm.563, 293–303 (2019).
   PubMedGoogle Scholar
• Van Dommelen SM , VaderP , LakhalSet al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Rel.161(2), 635–644 (2012).
   PubMed Web of Science ®Google Scholar
• Liu D , TanW , ZhouWet al. Synovial fibroblasts-derived exosomes overexpressing microrna-106b inhibits chondrocyte proliferation and migration via down-regulation of PDK4 in rheumatoid arthritis. Lancet (2019).
   PubMedGoogle Scholar
• Zheng J , ZhuL , IokIn I , ChenY , JiaN , ZhuW. Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Int. Immunopharmacol.78, 105985 (2020).
   PubMed Web of Science ®Google Scholar
• Kulkarni P , RawtaniD , BarotT. Formulation and optimization of long acting dual niosomes using Box-Behnken experimental design method for combinative delivery of ethionamide and D-cycloserine in tuberculosis treatment. colloids surfaces A physicochem. Eng. Asp.565, 131–142 (2019).
   Web of Science ®Google Scholar
• Paradkar M , VaghelaS. Thiocolchicoside niosomal gel formulation for the pain management of rheumatoid arthritis through topical drug delivery. Drug Deliv. Lett.8(2), 159–168 (2018).
   Google Scholar
• Abidin L , MujeebM , ImamSS , AqilM , KhuranaD. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Drug Deliv.23(3), 1079–1084 (2016).
   PubMed Web of Science ®Google Scholar
• Albuquerque J , MouraCC , SarmentoB , ReisS. Molecules solid lipid nanoparticles: a potential multifunctional approach towards rheumatoid arthritis theranostics. Molecules20, 11103–11118 (2015).
   PubMed Web of Science ®Google Scholar
• Hinge N , PandeyMM , SinghviGet al. Nanomedicine advances in cancer therapy. In: Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering.CL, ToitD, KumarP, ChoonaraYE, PillayV ( Eds). Woodhead Publishing, Sawston, Cambridge, 219–253 (2020).
   Google Scholar
• Zhou M , HouJ , ZhongZ , HaoN , LinY , LiC. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv.25(1), 716–722 (2018).
   PubMed Web of Science ®Google Scholar
• Aldayel AM , O'MaryHL , ValdesSAet al. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate. J. Control. Rel.283, 280–289 (2018).
   PubMed Web of Science ®Google Scholar
• Arora R , KuhadA , KaurIP , ChopraK. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur. J. Pain19(7), 940–952 (2015).
   PubMed Web of Science ®Google Scholar
• Waghule T , RapalliVK , SinghviGet al. Voriconazole loaded nanostructured lipid carriers based topical delivery system: qbD based designing, characterization, in-vitro and ex-vivo evaluation. J. Drug Deliv. Sci. Technol.52, 303–315 (2019).
   Web of Science ®Google Scholar
• Mahmood A , RapalliVK , WaghuleTet al. UV spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method: application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery. Spectrochim. Acta Part A Mol. Biomol. Spectrosc.235, 118310 (2020).
   PubMed Web of Science ®Google Scholar
• Rapalli VK , KaulV , GorantlaSet al. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: method development, in-vitro and ex-vivo applications in topical delivery. Spectrochim. Acta – Part A Mol. Biomol. Spectrosc.224, 117392 (2020).
   PubMed Web of Science ®Google Scholar
• Garg NK , TyagiRK , SinghBet al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. Int. J. Pharm.499(1–2), 301–320 (2016).
   PubMed Web of Science ®Google Scholar
• Singhvi G , BanerjeeS , KhosaA. Lyotropic liquid crystal nanoparticles. In: Organic Materials as Smart Nanocarriers for Drug Delivery.GrumezescuAM ( Ed.). William Andrew Publishing, CN, USA, 471–517 (2018).
   Google Scholar
• Singhvi G , ManchandaP , KrishnaRapalli V , KumarDubey S , GuptaG , DuaK. MicroRNAs as biological regulators in skin disorders. Biomed. Pharmacother.108, 996–1004 (2018).
   PubMed Web of Science ®Google Scholar
• Li Q , CaoJ , LiZ , ChuX. Cubic liquid crystalline gels based on glycerol monooleate for intra-articular injection. AAPS Pharm. Sci. Tech.9(2), 858–865 (2018).
   Google Scholar
• Salah S , MahmoudAA , KamelAO. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv.24(1), 846–856 (2017).
   PubMed Web of Science ®Google Scholar
• Vigderman L , ZubarevER. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv. Drug Deliv. Rev.65(5), 663–676 (2013).
   PubMed Web of Science ®Google Scholar
• Rawtani D , AgrawalYK. Study the interaction of DNA with halloysite nanotube-gold nanoparticle based composite. J. Bionanosci.6(2), 95–98 (2012).
   Google Scholar
• Kirdaite G , LeonavicieneL , BradunaiteRet al. Antioxidant effects of gold nanoparticles on early stage of collagen-induced arthritis in rats. Res. Vet. Sci.124, 32–37 (2019).
   PubMed Web of Science ®Google Scholar
• Gul A , KunwarB , MazharMet al. Rutin and rutin-conjugated gold nanoparticles ameliorate collagen-induced arthritis in rats through inhibition of NF-κB and iNOS activation. Int. Immunopharmacol.59, 310–317 (2018).
   PubMed Web of Science ®Google Scholar
• Lee H , LeeM-Y , BhangSHet al. Hyaluronate À gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. ACS Nano8(5), 4790–4798 (2014).
   PubMed Web of Science ®Google Scholar
• Waghule T , SinghviG , DubeySKet al. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed. Pharmacother.109, 1249–1258 (2019).
   PubMed Web of Science ®Google Scholar
• Shende P , SalunkeM. Transepidermal microneedles for co-administration of folic acid with methotrexate in the treatment of rheumatoid arthritis. Biomed. Phys. Eng. Express.5, 25023 (2019).
   Web of Science ®Google Scholar
• Yao W , TaoC , ZouJet al. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: a biocomfortable attempt to treat Rheumatoid Arthritis. Int. J. Pharm.563, 91–100 (2019).
   PubMed Web of Science ®Google Scholar
• Joshi N , YanJ , LevySet al. Towards an arthritis flare-responsive drug delivery system. Nat. Commun.9(1), 1–11 (2018).
   PubMedGoogle Scholar
• Yoshihara Y , NakamuraH , ObataKet al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis.59(6), 455–461 (2000).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov identifier: NCT00241982. https://clinicaltrials.gov/ct2/show/NCT00241982
   Google Scholar
• Yoon DH , BinSI , ChanSKCet al. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain. BMC Musculoskelet. Disord.18(1), 337 (2017).
   PubMedGoogle Scholar
• ClinicalTrials.gov identifier: NCT00524160. https://clinicaltrials.gov/ct2/show/NCT00524160
   Google Scholar
• ClinicalTrials.gov identifier: NCT00760669. https://clinicaltrials.gov/ct2/show/NCT00760669
   Google Scholar
• ClinicalTrials.gov identifier: NCT02030028. https://clinicaltrials.gov/ct2/show/NCT02030028
   Google Scholar
• ClinicalTrials.gov identifier: NCT03082573. https://clinicaltrials.gov/ct2/show/NCT03082573
   Google Scholar
• ClinicalTrials.gov identifier: NCT02434757. https://clinicaltrials.gov/ct2/show/NCT02434757
   Google Scholar
• ClinicalTrials.gov identifier: NCT02818361. https://clinicaltrials.gov/ct2/show/NCT02818361
   Google Scholar
• ClinicalTrials.gov identifier: NCT01966718. https://clinicaltrials.gov/ct2/show/NCT01966718
   Google Scholar
• ClinicalTrials.gov identifier: NCT03215407. https://clinicaltrials.gov/ct2/show/NCT03215407
   Google Scholar
• ClinicalTrials.gov identifier: NCT03445715. https://clinicaltrials.gov/ct2/show/NCT03445715
   Google Scholar
• ClinicalTrials.gov identifier: NCT01851278. https://clinicaltrials.gov/ct2/show/NCT01851278
   Google Scholar
• ClinicalTrials.gov identifier: NCT03337165. https://clinicaltrials.gov/ct2/show/NCT03337165
   Google Scholar
• ClinicalTrials.gov identifier: NCT00617032. https://clinicaltrials.gov/ct2/show/NCT00617032
   Google Scholar
• ClinicalTrials.gov identifier: NCT01352858. https://clinicaltrials.gov/ct2/show/NCT01352858
   Google Scholar
• ClinicalTrials.gov identifier: NCT00209859. https://clinicaltrials.gov/ct2/show/NCT00209859
   Google Scholar
• ClinicalTrials.gov identifier: NCT00244153. https://clinicaltrials.gov/ct2/show/NCT00244153
   Google Scholar
• Singhvi G , DubeySK , PatilS , GirdharV. Nanocarriers for topical drug delivery: approaches and advancements. Nanosci. Nanotechnology-Asia9(3), 329–336 (2018).
   Google Scholar
• Singhvi G , ManchandaP , HansN , DubeySK , GuptaG. Microsponge: an emerging drug delivery strategy. Drug Dev. Res.80(2), 200–208 (2019).
   PubMed Web of Science ®Google Scholar
• Škalko-Basnet N . Biologics: the role of delivery systems in improved therapy. Biol. Targets Ther.8, 107–114 (2014).
   PubMedGoogle Scholar
• Tharmavaram M , PandeyG , RawtaniD. Surface modified halloysite nanotubes: a flexible interface for biological, environmental and catalytic applications. Adv. Colloid Interface Sci.261, 82–101 (2018).
   PubMed Web of Science ®Google Scholar
• Rawtani D , AgrawalYK , PrajapatiP. Interaction behavior of DNA with halloysite nanotube-silver nanoparticle-based composite. Bionanoscience3(1), 73–78 (2013).
   Google Scholar
• Kulkarni P , RawtaniD. Application of Box-Behnken design in the preparation, optimization, and in vitro evaluation of self-assembly-based tamoxifen- and doxorubicin-loaded and dual drug-loaded niosomes for combinatorial breast cancer treatment. J. Pharm. Sci.108(8), 2643–2653 (2019).
   PubMed Web of Science ®Google Scholar
• Singhvi G , RapalliVK , NagpalS , DubeySK , SahaRN. Nanocarriers as potential targeted drug delivery for cancer therapy. In: Nanoscience in medicine (Volume 1).DaimaHK, PNN, RanjanS, Dasgupta, N, LichtfouseE ( Eds). Springer International Publishing, Cham, Switzerland, 51–83 (2020).
   Google Scholar
• Joseph E , SinghviG. Multifunctional nanocrystals for cancer therapy: a potential nanocarrier. In: Nanomaterials for Drug Delivery and Therapy.GrumezescuAM ( Ed.). William Andrew Publishing, CN, USA, 91–116 (2019).
   Google Scholar
• Singhvi G , PatilS , GirdharV , ChellappanDK , GuptaG , DuaK. 3D-printing: an emerging and a revolutionary technology in pharmaceuticals. Panminerva Med.60(4), 170–173 (2018).
   PubMed Web of Science ®Google Scholar
• Mahmood A , SinghviG , ManchandaPet al. Applications of 3D printing for the advancement of oral dosage forms. In: Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering.CL, ToitD, KumarP, ChoonaraYE, PillayY ( Eds). Woodhead Publishing, Sawston, Cambridge, 39–57 (2020).
   Google Scholar